Home > Quotes > ALKS > Company News
ALKS

Alkermes plc News Headlines

$31.515
*  
0.175
  negative  
0.55%
Get ALKS Alerts
*Delayed - data as of May 20, 2013 13:15 ET 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
View:    ALKS Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Alkermes, Plc (ALKS) - Bull of the Day
8/7/2012 1:00:01 AM - Zacks.com

Solid Quarter at ALKS, View Backed - Analyst Blog
7/31/2012 6:27:55 PM - Zacks.com

Pre-Market Earnings Report for July 26, 2012 : MMM, PLD, AGCO, ABB, ALK, ALKS, DDD, ASPS, ACIW, AIXG, ALU, AMAG
7/25/2012 4:08:28 PM - NASDAQ.com News

Alkermes, Plc (ALKS) - Bull of the Day
7/11/2012 1:00:01 AM - Zacks.com

Alkermes Upped to Outperform - Analyst Blog
7/10/2012 9:47:10 AM - Zacks.com

Zacks #1 Rank Additions for Monday - Tale of the Tape
7/2/2012 9:11:48 AM - Zacks.com

Pipeline Progress at Alkermes/JNJ - Analyst Blog
6/13/2012 9:54:20 AM - Zacks.com

Revenues Skyrocket at Merged Alkermes - Analyst Blog
5/18/2012 5:10:01 PM - Zacks.com

Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter
4/30/2012 8:30:10 PM - GuruFocus

Elan Sells 76% Stake in Alkermes - Analyst Blog
3/16/2012 5:06:01 PM - Zacks.com

Diabetes Market: Eli Lilly's Classic Pharma Vs. Sanofi Aventis' Modern Synergy
3/8/2012 6:24:00 PM - Seeking Alpha

Risk-Reward Balanced at Alkermes - Analyst Blog
3/6/2012 1:15:01 PM - Zacks.com

Bydureon Physician Survey: Results Yield Insight Into Launch Trajectory
2/22/2012 8:11:00 AM - Seeking Alpha

Opportunity In The Weight Loss Drug Market
2/21/2012 5:25:00 PM - Seeking Alpha

The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade Holding, Amylin Pharmaceuticals and Alkermes plc - Press Releases
2/16/2012 9:30:01 AM - Zacks.com

Amylin's Bydureon Launches in the US - Analyst Blog
2/15/2012 5:01:01 PM - Zacks.com

Elan's 4Q Loss Wider Than Expected - Analyst Blog
2/14/2012 11:30:01 AM - Zacks.com

Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
2/14/2012 4:41:00 AM - Seeking Alpha

Analyzing Friday's Noteworthy Insider Buys And Sells
2/12/2012 7:06:00 AM - Seeking Alpha

Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
2/7/2012 2:36:00 AM - Seeking Alpha

Novo Nordisk Posts Solid 4Q - Analyst Blog
2/6/2012 10:30:01 AM - Zacks.com

The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company - Press Releases
2/6/2012 9:30:01 AM - Zacks.com

Friday's Noteworthy Insider Buys And Sells In The Technology And Healthcare Sectors
2/5/2012 5:10:00 AM - Seeking Alpha

Revenues Skyrocket at Merged Alkermes - Analyst Blog
2/3/2012 11:15:01 AM - Zacks.com

Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
2/3/2012 4:09:00 AM - Seeking Alpha